September 14, 2017 / 11:40 AM / 3 months ago

BRIEF-Innovation Pharmaceuticals opens new clinical site for novel p53 drug candidate in Phase 2 ovarian cancer trial

Sept 14 (Reuters) - Innovation Pharmaceuticals Inc

* Innovation Pharmaceuticals opens new clinical site for novel p53 drug candidate in Phase 2 ovarian cancer trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below